POST SUMMARY: Innovation is one of the key elements to help biopharma companies overcome the challenges that face them, but are mergers going to lead to more innovation or burdensome processes designed to slow innovation to a crawl.
POST SUMMARY: Innovation is one of the key elements to help biopharma companies overcome the challenges that face them, but are mergers going to lead to more innovation or burdensome processes designed to slow innovation to a crawl.